Jimin Fei

542 total citations · 1 hit paper
10 papers, 398 citations indexed

About

Jimin Fei is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Jimin Fei has authored 10 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Otorhinolaryngology. Recurrent topics in Jimin Fei's work include Autophagy in Disease and Therapy (3 papers), Head and Neck Cancer Studies (3 papers) and Cancer-related Molecular Pathways (3 papers). Jimin Fei is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Head and Neck Cancer Studies (3 papers) and Cancer-related Molecular Pathways (3 papers). Jimin Fei collaborates with scholars based in China, Australia and United States. Jimin Fei's co-authors include Yueqin Zhao, Yang Xu, Yinyuan Wang, Xiao‐Jiang Hao, Xiao Ding, Xing‐Zhi Yang, Liming Gui, Yuhan Zhao, Shun‐Lin Li and Juan Wang and has published in prestigious journals such as International Journal of Cancer, Cancer Letters and Annals of Surgical Oncology.

In The Last Decade

Jimin Fei

9 papers receiving 397 citations

Hit Papers

Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 si... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jimin Fei China 5 236 216 176 62 53 10 398
Junjun Ling China 12 219 0.9× 103 0.5× 97 0.6× 13 0.2× 100 1.9× 37 368
Shuai Chen China 11 143 0.6× 75 0.3× 79 0.4× 12 0.2× 64 1.2× 32 292
Haimiao Xu China 10 193 0.8× 89 0.4× 109 0.6× 8 0.1× 80 1.5× 27 394
Amr S. Saad Egypt 10 199 0.8× 52 0.2× 168 1.0× 14 0.2× 107 2.0× 18 345
Mee-Hyun Lee South Korea 3 220 0.9× 85 0.4× 102 0.6× 6 0.1× 127 2.4× 5 369
Shilian Chen China 10 296 1.3× 101 0.5× 150 0.9× 5 0.1× 103 1.9× 18 433
Beili Gao China 10 122 0.5× 106 0.5× 42 0.2× 9 0.1× 135 2.5× 24 278
Shaoqian Sun China 10 121 0.5× 132 0.6× 108 0.6× 7 0.1× 240 4.5× 14 453
Shuchen Lin China 11 245 1.0× 170 0.8× 168 1.0× 4 0.1× 156 2.9× 26 494
Funan Liu China 13 224 0.9× 153 0.7× 118 0.7× 4 0.1× 106 2.0× 25 444

Countries citing papers authored by Jimin Fei

Since Specialization
Citations

This map shows the geographic impact of Jimin Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jimin Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jimin Fei more than expected).

Fields of papers citing papers by Jimin Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jimin Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jimin Fei. The network helps show where Jimin Fei may publish in the future.

Co-authorship network of co-authors of Jimin Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Jimin Fei. A scholar is included among the top collaborators of Jimin Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jimin Fei. Jimin Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Xiang, Xudong, Jimin Fei, Xian Zhao, et al.. (2025). NCAPH promotes immune evasion via inhibiting PD-L1 protein degradation in head and neck squamous cell carcinoma. Cancer Letters. 639. 218218–218218.
2.
Xu, Yang, Xiao Ding, Yueqin Zhao, et al.. (2025). Isowalsuranolide targets TrxR1/2 and triggers lysosomal biogenesis and autophagy via the p53-TFEB/TFE3 axis. Science China Life Sciences. 68(5). 1437–1451. 1 indexed citations
3.
Ding, Xiao, Yang Xu, Yueqin Zhao, et al.. (2022). Identification of active natural products that induce lysosomal biogenesis by lysosome-based screening and biological evaluation. Heliyon. 8(10). e11179–e11179. 4 indexed citations
4.
Zhao, Yueqin, Yang Xu, Jimin Fei, et al.. (2021). Identification of limonoids from Walsura yunnanensis and evaluation of their cytotoxicity against cancer cell lines. Fitoterapia. 157. 105120–105120. 5 indexed citations
5.
Zhao, Yueqin, Juan Wang, Yang Xu, et al.. (2021). Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. International Journal of Biological Sciences. 17(11). 2703–2717. 302 indexed citations breakdown →
6.
Fei, Jimin, Wen Zeng, Yukun Liu, et al.. (2019). The molecular basis for p53 inhibition of autophagy in porcine fibroblast cells. Translational Cancer Research. 8(3). 876–886. 1 indexed citations
7.
Fei, Jimin, Yukun Liu, Deling Jiao, et al.. (2019). The molecular basis for p53 inhibition of autophagy in porcine fibroblast cells. Translational Cancer Research. 8(3). 876–886. 3 indexed citations
8.
Zhong, Zhaoming, Yue Jiang, Jimin Fei, et al.. (2014). Clinical and prognostic analysis of second primary squamous cell carcinoma of the tongue after radiotherapy for nasopharyngeal carcinoma. British Journal of Oral and Maxillofacial Surgery. 52(8). 715–720. 13 indexed citations
9.
Hong, Angela, Timothy Dobbins, D. Brian Jones, et al.. (2010). Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer. International Journal of Cancer. 128(7). 1532–1545. 29 indexed citations
10.
Fei, Jimin, Angela Hong, Timothy Dobbins, et al.. (2009). Prognostic Significance of Vascular Endothelial Growth Factor in Squamous Cell Carcinomas of the Tonsil in Relation to Human Papillomavirus Status and Epidermal Growth Factor Receptor. Annals of Surgical Oncology. 16(10). 2908–2917. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026